Skip to main content

Table 2 The characteristics of patients with Kawasaki disease according to development of CADs

From: A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease

 

CADs (-) N = 740

CADs ( +) N = 156

P value

Age, months

31.86 ± 22.54

32.92 ± 26.15

0.60

Sex

  

0.53

 Male, n (%)

418 (56.4%)

93 (59.6%)

 

 Female, n (%)

322 (43.5%)

63 (40.3%)

 

WBC, 103/L

14.73 ± 4.75

15.22 ± 5.10

0.25

ANC, 103/L

9.59 ± 4.44

10.71 ± 4.87

 < 0.01

Hematocrit, %

34.40 ± 13.06

34.33 ± 5.08

0.94

Platelet, 103/L

358.78 ± 101.58

346.15 ± 103.82

0.16

AST, U/L

83.23 ± 144.13

103.38 ± 169.70

0.12

ALT, U/L

81.05 ± 130.57

129.67 ± 169.03

 < 0.01*

Albumin, g/dL

3.97 ± 0.95

3.82 ± 0.44

0.04

Total bilirubin, mg/dL

0.64 ± 0.82

1.04 ± 1.14

 < 0.01*

CRP, mg/dL

7.94 ± 5.68

9.77 ± 6.85

 < 0.01*

Na, mmol/L

136.37 ± 2.71

135.67 ± 3.01

 < 0.01*

NT-proBNP, pg/mL

1192.48 ± 2049.08

2268.57 ± 4136.75

 < 0.01*

IVIG resistance, n (%)

72 (9.7%)

39 (25.0%)

 < 0.01*

  1. mean ± standard deviation or number (%). *means statistically significant; p values < 0.05
  2. IVIG Intravenous immunoglobulin, WBC White blood cells, ANC Absolute neutrophil counts, AST Aspartate aminotransferase, ALT Alanine transaminase, CRP C-reactive protein, NT-proBNP Nitrogen terminal- pro brain natriuretic peptide, CAD Coronary artery dilatation
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us